614 related articles for article (PubMed ID: 10192355)
1. Iridium-192 transperineal interstitial brachytherapy for locally advanced or recurrent gynecological malignancies.
Gupta AK; Vicini FA; Frazier AJ; Barth-Jones DC; Edmundson GK; Mele E; Gustafson GS; Martinez AA
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1055-60. PubMed ID: 10192355
[TBL] [Abstract][Full Text] [Related]
2. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
[TBL] [Abstract][Full Text] [Related]
3. Transperineal low-dose rate iridium-192 interstitial brachytherapy in cervical carcinoma stage IIB.
Budrukkar AN; Shrivastava SK; Jalali R; Agarwal JP; Deshpande DD; Nehru RM; Dinshaw KA
Strahlenther Onkol; 2001 Oct; 177(10):517-24. PubMed ID: 11680016
[TBL] [Abstract][Full Text] [Related]
4. Pulsed dose rate (PDR) brachytherapy as salvage treatment of locally advanced or recurrent gynecologic cancer.
Jensen PT; Roed H; Engelholm SA; Rosendal F
Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1041-7. PubMed ID: 9869227
[TBL] [Abstract][Full Text] [Related]
5. The role of interstitial brachytherapy using template in locally advanced gynecological malignancies.
Agrawal PP; Singhal SS; Neema JP; Suryanarayan UK; Vyas RK; Rathi AK; Bahadur AK
Gynecol Oncol; 2005 Oct; 99(1):169-75. PubMed ID: 16081150
[TBL] [Abstract][Full Text] [Related]
6. Retrospective analysis of role of interstitial brachytherapy using template (MUPIT) in locally advanced gynecological malignancies.
Nandwani PK; Vyas RK; Neema JP; Suryanarayan UK; Bhavsar DC; Jani KR
J Cancer Res Ther; 2007; 3(2):111-5. PubMed ID: 17998736
[TBL] [Abstract][Full Text] [Related]
7. Perineal template interstitial brachytherapy salvage for recurrent endometrial adenocarcinoma metastatic to the vagina.
Nag S; Martínez-Monge R; Copeland LJ; Vacarello L; Lewandowski GS
Gynecol Oncol; 1997 Jul; 66(1):16-9. PubMed ID: 9234914
[TBL] [Abstract][Full Text] [Related]
8. HDR interstitial perineal implant for locally advanced or recurrent uterine cervix cancer.
Susworo R; Supriana N; Ramli I
Radiat Med; 2004; 22(1):2-5. PubMed ID: 15053165
[TBL] [Abstract][Full Text] [Related]
9. Predictors of severe gastrointestinal toxicity after external beam radiotherapy and interstitial brachytherapy for advanced or recurrent gynecologic malignancies.
Kasibhatla M; Clough RW; Montana GS; Oleson JR; Light K; Steffey BA; Jones EL
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):398-403. PubMed ID: 16542793
[TBL] [Abstract][Full Text] [Related]
10. Combination of external beam irradiation and multiple-site perineal applicator (MUPIT) for treatment of locally advanced or recurrent prostatic, anorectal, and gynecologic malignancies.
Martinez A; Edmundson GK; Cox RS; Gunderson LL; Howes AE
Int J Radiat Oncol Biol Phys; 1985 Feb; 11(2):391-8. PubMed ID: 3918967
[TBL] [Abstract][Full Text] [Related]
11. High-dose-rate interstitial brachytherapy for gynecologic malignancies.
Beriwal S; Bhatnagar A; Heron DE; Selvaraj R; Mogus R; Kim H; Gerszten K; Kelley J; Edwards RP
Brachytherapy; 2006; 5(4):218-22. PubMed ID: 17118313
[TBL] [Abstract][Full Text] [Related]
12. Template-based high-dose-rate interstitial brachytherapy in gynecologic cancers: a single institutional experience.
Mahantshetty U; Shrivastava S; Kalyani N; Banerjee S; Engineer R; Chopra S
Brachytherapy; 2014; 13(4):337-42. PubMed ID: 24176863
[TBL] [Abstract][Full Text] [Related]
13. High dose rate transperineal interstitial brachytherapy for cervical cancer: high pelvic control and low complication rates.
Demanes DJ; Rodriguez RR; Bendre DD; Ewing TL
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):105-12. PubMed ID: 10477013
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of freehand interstitial brachytherapy in advanced gynecologic malignancies.
Bajwa HK; Singareddy R; Krishnam Raju A
Brachytherapy; 2020; 19(5):669-673. PubMed ID: 32466952
[TBL] [Abstract][Full Text] [Related]
15. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
16. Interstitial hyperthermia and iridium-192 treatment alone vs. interstitial iridium-192 treatment/hyperthermia and low dose cisplatinum infusion in the treatment of locally advanced head and neck malignancies.
Schreiber DP; Overett TK
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):429-36. PubMed ID: 7673030
[TBL] [Abstract][Full Text] [Related]
17. Pulsed low dose rate brachytherapy for uterine cervix carcinoma.
Rogers CL; Freel JH; Speiser BL
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):95-100. PubMed ID: 9989519
[TBL] [Abstract][Full Text] [Related]
18. A multiple-site perineal applicator (MUPIT) for treatment of prostatic, anorectal, and gynecologic malignancies.
Martinez A; Cox RS; Edmundson GK
Int J Radiat Oncol Biol Phys; 1984 Feb; 10(2):297-305. PubMed ID: 6706724
[TBL] [Abstract][Full Text] [Related]
19. Reirradiation with high-dose-rate remote afterloading brachytherapy implant in patients with locally recurrent or residual cervical carcinoma.
Badakh DK; Grover AH
J Cancer Res Ther; 2009; 5(1):24-30. PubMed ID: 19293485
[TBL] [Abstract][Full Text] [Related]
20. Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: analysis of dose and fractionation schedule.
Toita T; Kakinohana Y; Ogawa K; Adachi G; Moromizato H; Nagai Y; Maehama T; Sakumoto K; Kanazawa K; Murayama S
Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1344-53. PubMed ID: 12873679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]